EcoDrugPlus

Protein Kinase C, Beta

Ensembl ID : ENSMSIG00000028305
Gene Symbol: PRKCB
1 Cross references
299 Possible Orthologues:

Protein Kinase C, Delta

Ensembl ID : ENSMSIG00000028700
Gene Symbol: PRKCD
1 Cross references
295 Possible Orthologues:

Protein Kinase C, Epsilon

Ensembl ID : ENSMSIG00000010675
Gene Symbol: PRKCE
1 Cross references
330 Possible Orthologues:

Protein Kinase C, Eta

Ensembl ID : ENSMSIG00000024638
Gene Symbol: PRKCH
1 Cross references
252 Possible Orthologues:

Protein Kinase C, Gamma

Ensembl ID : ENSMSIG00000000769
Gene Symbol: PRKCG
1 Cross references
214 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSMSIG00000009255
Gene Symbol: PRKCI
1 Cross references
208 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSMSIG00000025717
Gene Symbol: PRKCQ
1 Cross references
218 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSMSIG00000016904
Gene Symbol: PRKCZ
1 Cross references
215 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSMSIG00000008215
Gene Symbol: PRKD3
1 Cross references
285 Possible Orthologues:

Protein Kinase, Dna Activated, Catalytic Polypeptide

Ensembl ID : ENSMSIG00000016274
Gene Symbol: PRKDC
1 Cross references
199 Possible Orthologues:

Protein Kinase, Camp Dependent, Catalytic, Alpha

Ensembl ID : ENSMSIG00000012589
Gene Symbol: PRKACA
1 Cross references
296 Possible Orthologues:

Protein Kinase, Camp Dependent, Catalytic, Beta

Ensembl ID : ENSMSIG00000007822
Gene Symbol: PRKACB
1 Cross references
314 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).